Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Gravas S, Tzortzis V, Melekos MD (2008) Translation of benign prostatic hyperplasia guidelines into clinical practice. CurrOpinUrol 18:56–60
2. Suarez-Ibarrola R, Miernik A, Gratzke C, Schoeb DS (2020) Reasons for new MIS. Let’s be fair: iTIND, Urolift and Rezūm. World J Urol. https://doi.org/10.1007/s00345-020-03453-z (Online ahead of print)
3. Madersbacher S, Roehrborn CG, Oelke M (2020) The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int 126(3):317–326. https://doi.org/10.1111/bju.15154
4. Lebdai S, Chevrot A, Doizi S et al (2019) Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment. World J Urol 37(2):299–308. https://doi.org/10.1007/s00345-018-2368-6
5. Speakman MJ, Cornu JN, Gacci M et al (2019) What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction? EurUrol Focus 5:351–356
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献